Pfizer Inc. / PFE

Дата на съобщението : 14.04.2024 20:08
Тип на съобщението : Напомняне за събитие, което вече е обявено
ISIN : US7170811035
Тип на събитието : Годишно общо събрание
Описание на събитието : Свикване на годишно общо събрание на акционерите.

---

Дата на обявяване на събитието: 14.03.2024 г.
Съобщението се отнася за лицата, вписани като акционери към дата: 28.02.2024 г.
Дата на провеждане на общо събрание: 25.04.2024 г.



Допълнителна информация
AGM Meeting Agenda:
1.1. Elect Director Ronald E. Blaylock (For, Against, Abstain, Do Not Vote)
1.2. Elect Director Albert Bourla (For, Against, Abstain, Do Not Vote)
1.3. Elect Director Susan Desmond Hellmann (For, Against, Abstain, Do Not Vote)
1.4. Elect Director Joseph J. Echevarria (For, Against, Abstain, Do Not Vote)
1.5. Elect Director Scott Gottlieb (For, Against, Abstain, Do Not Vote)
1.6. Elect Director Helen H. Hobbs (For, Against, Abstain, Do Not Vote)
1.7. Elect Director Susan Hockfield (For, Against, Abstain, Do Not Vote)
1.8. Elect Director Dan R. Littman (For, Against, Abstain, Do Not Vote)
1.9. Elect Director Shantanu Narayen (For, Against, Abstain, Do Not Vote)
1.10. Elect Director Suzanne Nora Johnson (For, Against, Abstain, Do Not Vote)
1.11. Elect Director James Quincey (For, Against, Abstain, Do Not Vote)
1.12. Elect Director James C. Smith (For, Against, Abstain, Do Not Vote)
2. Ratify KPMG LLP as Auditors (For , Against, Abstain, Do Not Vote)
3. Amend Omnibus Stock Plan (For, Against, Abstain, Do Not Vote)
4. Advisory Vote to Ratify Named Executive Officers' Compensation (For, Against, Abstain, Do Not Vote)
5. Require Independent Board Chair (For, Against, Abstain, Do Not Vote)
6. Report on Congruency of Political Spending with Company Stated Values and Priorities (For, Against, Abstain, Do Not Vote)
7. Amend Director Resignation Processes Withdrawn Resolution 8. Report on Corporate Contributions (For, Against, Abstain, Do Not Vote)
Blocking: No Country: US Partial Vote: Yes Split Vote: Yes
ALERT:
Please be informed that this meeting was regressed to mark item 7 - Amend Director Resignation Processes as a withdrawn resolution. Management recommendation changed from Against to None and VVO changed from F,Ag ,Ab,DNV to N. ATTENTION: SECURITIES ADM/CORPORATE ACTIONS/REORG FOR INQUIRIES PLEASE CONTACT YOUR REGULAR CUSTOMER SUPPORT TEAM PLEASE FIND FURTHER INFORMATION ABOUT DATA PROTECTION ON OUR WEBSITE: https://www.clearstream.com/clearst ream-en/about-clearstream/due-dilig ence/gdpr/dataprotection